During @ years of followup statin drug use during the trial was not associated with the risk of total prostate cancer ( HR @ , @ % CI @-@ @ ) , or lower grade ( HR @ , @ % CI @-@ @ ) or higher grade ( HR @ , @ % CI @-@ @ ) prostate cancer .